J Bellmunt

2.5k total citations · 1 hit paper
31 papers, 1.9k citations indexed

About

J Bellmunt is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Bellmunt has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Bellmunt's work include Bladder and Urothelial Cancer Treatments (6 papers), Advanced Breast Cancer Therapies (3 papers) and Renal cell carcinoma treatment (3 papers). J Bellmunt is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Advanced Breast Cancer Therapies (3 papers) and Renal cell carcinoma treatment (3 papers). J Bellmunt collaborates with scholars based in Spain, United States and United Kingdom. J Bellmunt's co-authors include Thomas Powles, Nicholas J. Vogelzang, M. Bolla, Steven Joniau, F. Zattoni, A Heidenreich, Theodorus van der Kwast, Nicolas Mottet, Thomas Wiegel and Myfanwy Morgan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

J Bellmunt

31 papers receiving 1.9k citations

Hit Papers

前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療 2011 2026 2016 2021 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療
    2011 741 citations A Heidenreich, J Bellmunt et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Bellmunt Spain 14 967 751 434 420 413 31 1.9k
R. Sylvester Belgium 21 976 1.0× 637 0.8× 287 0.7× 686 1.6× 207 0.5× 54 1.9k
Atsuhiko Sakamoto Japan 28 397 0.4× 1.0k 1.3× 277 0.6× 648 1.5× 422 1.0× 126 3.5k
Daniel Sudilovsky United States 15 509 0.5× 623 0.8× 250 0.6× 214 0.5× 254 0.6× 32 1.6k
Francesco Schettini Italy 22 641 0.7× 861 1.1× 463 1.1× 116 0.3× 173 0.4× 113 2.0k
C. Logothetis United States 23 1.1k 1.1× 817 1.1× 403 0.9× 1.0k 2.4× 90 0.2× 71 2.4k
Christian Wülfing Germany 22 786 0.8× 508 0.7× 356 0.8× 634 1.5× 98 0.2× 113 1.9k
Raymond S. Lance United States 24 1.4k 1.5× 647 0.9× 509 1.2× 440 1.0× 71 0.2× 51 2.6k
John Naitoh United States 14 826 0.9× 343 0.5× 169 0.4× 233 0.6× 98 0.2× 31 1.3k
Eijiro Nakamura Japan 19 472 0.5× 574 0.8× 241 0.6× 233 0.6× 147 0.4× 59 1.4k
Riichiroh Maruyama Japan 24 1.2k 1.2× 820 1.1× 345 0.8× 318 0.8× 147 0.4× 69 2.6k

Countries citing papers authored by J Bellmunt

Since Specialization
Citations

This map shows the geographic impact of J Bellmunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Bellmunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Bellmunt more than expected).

Fields of papers citing papers by J Bellmunt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Bellmunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Bellmunt. The network helps show where J Bellmunt may publish in the future.

Co-authorship network of co-authors of J Bellmunt

This figure shows the co-authorship network connecting the top 25 collaborators of J Bellmunt. A scholar is included among the top collaborators of J Bellmunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Bellmunt. J Bellmunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellmunt, J, Thomas Powles, & Nicholas J. Vogelzang. (2017). A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now. Cancer Treatment Reviews. 54. 58–67. 275 indexed citations
2.
Heidenreich, A, J Bellmunt, M. Bolla, et al.. (2011). 前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療. European Urology. 59(1). 61–71. 741 indexed citations breakdown →
3.
Cebrián, Virginia, Esteban Orenes‐Piñero, Laura Grau, et al.. (2011). KISS1 Methylation and Expression as Tumor Stratification Biomarkers and Clinical Outcome Prognosticators for Bladder Cancer Patients. American Journal Of Pathology. 179(2). 540–546. 47 indexed citations
4.
Ruppen, Isabel, Laura Grau, Esteban Orenes‐Piñero, et al.. (2010). Differential Protein Expression Profiling by iTRAQ-Two-dimensional LC-MS/MS of Human Bladder Cancer EJ138 Cells Transfected with the Metastasis Suppressor KiSS-1 Gene. Molecular & Cellular Proteomics. 9(10). 2276–2291. 51 indexed citations
5.
Karakiewicz, Pierre I., Maxine Sun, J Bellmunt, Vesna Šneller, & Bernard Escudier. (2010). Prediction of Progression-Free Survival Rates After Bevacizumab Plus Interferon Versus Interferon Alone in Patients with Metastatic Renal Cell Carcinoma: Comparison of a Nomogram to the Motzer Criteria. European Urology. 60(1). 48–56. 18 indexed citations
6.
Bellmunt, J, Santiago Albiol, & Vesa Kataja. (2009). 浸潤性膀胱癌:診断,治療および経過観察に関するESMO(欧州臨床腫瘍学会議)の臨床勧告. Annals of Oncology. 20. 10–14. 37 indexed citations
7.
Orenes‐Piñero, Esteban, Thorsten Ecke, Marta Gil, et al.. (2009). DISCOVERY OF THE METHYLATION OF THE METASTASIS SUPPRESSOR GENE, KISS-1, IN BLADDER CANCER. The Journal of Urology. 181(4S). 374–374. 1 indexed citations
8.
Cebrián, Virginia, Virginia López, Esteban Orenes‐Piñero, et al.. (2008). Identification of PMF1 Methylation in Association with Bladder Cancer Progression. Clinical Cancer Research. 14(24). 8236–8243. 29 indexed citations
9.
Margarit, Carlos, Alfredo Escartín, J Bellmunt, Elena Allende, & Itxarone Bilbao. (2006). Colangiocarcinoma periférico: resultados del tratamiento quirúrgico. Gastroenterología y Hepatología. 29(4). 215–223. 5 indexed citations
10.
Bellmunt, J, et al.. (2002). Feasibility Trial of Methotrexate–Paclitaxel as a Second Line Therapy in Advanced Urothelial Cancer. Cancer Investigation. 20(5-6). 673–685. 27 indexed citations
11.
Buesa, J., Antonio López–Pousa, Javier Martín‐Broto, et al.. (1998). Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: A study of the Spanish Group for Research on Sarcomas (GEIS). Annals of Oncology. 9(8). 871–876. 50 indexed citations
12.
Bellmunt, J, et al.. (1997). Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis. Cancer Chemotherapy and Pharmacology. 40(3). 273–276. 6 indexed citations
13.
Ribas, A., et al.. (1997). Life-threatening toxicity of oral tegafur-uracil (UFT) plus leucovorin. Clinical Oncology. 9(4). 269–270. 1 indexed citations
14.
Albanell, Joan, J Bellmunt, Raquel Molina, et al.. (1996). Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis.. PubMed. 16(2). 1027–32. 40 indexed citations
15.
Bellmunt, J, et al.. (1992). Interferon and disseminated langerhans cell histiocytosis. Medical and Pediatric Oncology. 20(4). 336–337. 11 indexed citations
16.
Bellmunt, J, et al.. (1990). Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines. Cancer Chemotherapy and Pharmacology. 26(S1). S81–S84. 12 indexed citations
17.
Felip, Enriqueta, et al.. (1990). Addison's Disease Secondary to Prostatic Carcinoma. A Case Report. Tumori Journal. 76(6). 611–613. 7 indexed citations
18.
Bellmunt, J, et al.. (1990). Capillary microscopy is a potentially useful method for detecting bleomycin vascular toxicity. Cancer. 65(2). 303–309. 15 indexed citations
19.
Almirante, Benito, et al.. (1989). Fatal septic thrombophlebitis due toSalmonella enteritidis. European Journal of Clinical Microbiology & Infectious Diseases. 8(1). 82–83. 4 indexed citations
20.
Palou, Juan, et al.. (1988). Wilms’ Tumor in an Adult Patient. Urologia Internationalis. 43(6). 349–351. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Sylvester Breakdown of academic impact, for papers by Atsuhiko Sakamoto Breakdown of academic impact, for papers by Daniel Sudilovsky Breakdown of academic impact, for papers by Francesco Schettini Breakdown of academic impact, for papers by C. Logothetis Breakdown of academic impact, for papers by Christian Wülfing Breakdown of academic impact, for papers by Raymond S. Lance Breakdown of academic impact, for papers by John Naitoh Breakdown of academic impact, for papers by Eijiro Nakamura Breakdown of academic impact, for papers by Riichiroh Maruyama
Rankless by CCL
2026